Anti-Aging Therapy With Human Growth Hormone Associated With Metastatic Colon Cancer in a Patient With Crohn's Colitis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 3, 2008, Pages 360-363

  Melmed, Gil Y ^a   Devlin, Shane M ^a   Vlotides, George ^a   Dhall, Deepti ^a   Ross, Soraya ^a   Yu, Run ^a   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; MESALAZINE; PRASTERONE; PREDNISONE; RNA; SOMATOMEDIN C RECEPTOR; TESTOSTERONE; VASCULOTROPIN;

AGED; AGING; ARTICLE; CANCER PATIENT; CANCER RISK; CASE REPORT; COLON; COLON CANCER; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METASTASIS; MOLECULE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SUPPLEMENTATION;

AGED; AGING; COLONIC NEOPLASMS; CROHN DISEASE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; MALE; NEOPLASM METASTASIS; RECOMBINANT PROTEINS;

EID: 39949084302     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.12.017     Document Type: Article

References (26)

1. Gharib H., Cook D.M., Saenger P.H., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr Pract 9 (2003) 64-76
2. Perls T.T., Reisman N.R., and Olshansky S.J. Provision or distribution of growth hormone for "antiaging": clinical and legal issues. JAMA 294 (2005) 2086-2090
3. Vance M.L. Can growth hormone prevent aging?. N Engl J Med 348 (2003) 779-780
4. Liu H., Bravata D.M., Olkin I., et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 146 (2007) 104-115
5. Melmed S. Supplemental growth hormone in healthy adults: the endocrinologist's responsibility. Nat Clin Pract Endocrinol Metab 2 (2006) 119
6. Ma J., Pollak M.N., Giovannucci E., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
7. Giovannucci E., Pollak M.N., Platz E.A., et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9 (2000) 345-349
8. Kaaks R., Toniolo P., Akhmedkhanov A., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92 (2000) 1592-1600
9. Jenkins P.J. Acromegaly and cancer. Horm Res 62 Suppl 1 (2004) 108-115
10. Domenech-Santasusana M., Carles J., Goday A., et al. Association of acromegaly and two malignancies: colorectal cancer and non-Hodgkin's lymphoma. Ann Oncol 5 (1994) 659
11. Jenkins P.J., and Fairclough P.D. Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut 51 Suppl 5 (2002) V13-V14
12. Miller M.E., Michaylira C.Z., Simmons J.G., et al. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127 (2004) 570-581
13. Wu Y., Yakar S., Zhao L., et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62 (2002) 1030-1035
14. Warren R.S., Yuan H., Matli M.R., et al. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 271 (1996) 29483-29488
15. Swerdlow A.J., Higgins C.D., Adlard P., et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360 (2002) 273-277
16. Sperling M.A., Saenger P.H., Hintz R., et al. Special editorial: growth hormone treatment and neoplasia-coincidence or consequence?. J Clin Endocrinol Metab 87 (2002) 5351-5352
17. Lahm H., Amstad P., Wyniger J., et al. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58 (1994) 452-459
18. Reinmuth N., Fan F., Liu W., et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82 (2002) 1377-1389
19. Michaylira C.Z., Ramocki N.M., Simmons J.G., et al. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology 147 (2006) 1632-1641
20. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131 (2001) 3109S-3120S
21. Theiss A.L., Fruchtman S., and Lund P.K. Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I. Inflamm Bowel Dis 10 (2004) 871-880
22. Slonim A.E., Bulone L., Damore M.B., et al. A preliminary study of growth hormone therapy for Crohn's disease. N Engl J Med 342 (2000) 1633-1637
23. Sinha A., Nightingale J., West K.P., et al. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349 (2003) 350-357
24. Hakam A., Yeatman T.J., Lu L., et al. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum Pathol 30 (1999) 1128-1133
25. Weber M.M., Fottner C., Liu S.B., et al. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 95 (2002) 2086-2095
26. Itzkowitz S.H. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 35 (2006) 553-571